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Vibrational spectroscopic techniques can detect small
variations in molecular content, linked with disease, showing
promise for screening and early diagnosis. Biological fluids,
particularly blood serum, are potentially valuable for
diagnosis purposes. The so-called Low Molecular Weight
Fraction (LMWF) contains the associated peptidome and
metabolome and has been identified as potentially the most
relevant molecular population for disease-associated
biomarker research. Although vibrational spectroscopy can
deliver a specific chemical fingerprint of the samples, the
High Molecular Weight Fraction (HMWF), composed of the
most abundant serum proteins, strongly dominates the
response and ultimately makes the detection of minor
spectral variations a challenging task. Spectroscopic
detection of potential serum biomarkers present at relatively
low concentrations can be improved using pre-analytical
depletion of the HMWF. In the present study, human serum
fractionation by centrifugal filtration was used prior to
analysis by Attenuated Total Reflection infrared
spectroscopy. Using a model sample based on glycine spiked
serum, it is demonstrated that the screening of the LMWF
can be applied to quantify blinded concentrations up to 50
times lower. Moreover, the approach is easily transferable to
different bodily fluids which would support the development
of more efficient and suitable clinical protocols exploring
vibrational spectroscopy based ex-vivo diagnostic tools.
Revealing serum LMWF for spectral serological diagnostic
applications
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1. Introduction
Vibrational spectroscopic techniques have been
extensively evaluated for their capacity to deliver a
specific molecular fingerprint closely linked to the
disease state [1-5]. Ranging from tissue to single cell
analysis, both infrared and Raman spectroscopy are
promising techniques with potential clinical applications
[6]. Spectral imaging of biopsies using FTIR or Raman
confocal micro-spectroscopy has proven the potential of
these approaches for the identification of pathological
areas delivering additional histological information for
diagnosis based on the molecular profiles of the samples.
Applied to single cell analysis, the specificity of the
techniques allows in vitro screening of toxicological
effects of ionising radiation, nanoparticles or the action
of chemotherapeutic agents at the subcellular level [7-12].
Recently, vibrational spectroscopy in the field of spectral
cytology performed on cervical samples for the detection
of abnormal cells based on their chemical composition
has attracted more attention [13, 14]. However, diseases
such as cancer could remain asymptomatic until they
reach a stage of development too advanced for effective
treatment, and therefore routine screening for early
detection is crucial to improve patient prognosis. In this
context, bodily fluids are of great interest [15], and,
although urine or saliva could be attractive candidates for
patients screening and monitoring [16, 17], blood serum
remains potentially the most valuable alternative to
identify reliable biomarkers for diagnosis purposes [18].
The development of proteomic technologies with
medical perspectives needs to align with clinical
requirements such as compatibility with large patient
cohort analysis, speed and cost effectiveness to enable
clinical translation of these promising technologies.
Analysis of human serum for the identification of
disease-associated biomarkers is a challenging task, with
numerous obstacles to overcome. For instance, in recent
studies investigating the feasibility to develop methods
for proteomic investigation, the high protein content (i.e.
60–80 mg/ml) could be interpreted as a beneficial
attribute of the sample [19]. Indeed, with about 25% of
all proteins encoded by the genome predicted to be
secreted, serum is a rich source of biochemical products
that can act as biomarkers of disease or physiological
status of a patient [20]. It is expected that, by measuring
concentrations of specific molecular species in the serum,
the presence of disease associated proteins being secreted
and shed from cells and tissues can be determined. For
example, increased serum levels of prostate-specific
antigen (PSA) and CA125 are routinely used for the in
vitro detection of cancer in the prostate and ovary in
clinic routines [21]. However, the main limiting
characteristic of the serum is the dynamic range of
concentrations observed between the abundant, high
molecular weight and the sparse, low molecular weight
proteins. As a part of the high molecular weight fraction
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(HMWF), proteins such as human serum albumin (HSA)
(57–71%) and globulins (8–26%), completely dominate
the composition of the serum quantitatively but only
account for 0.1% of the total number of protein species.
Consequently, many potentially important molecules and
markers can escape detection, due to difficulties in
monitoring the smaller, less abundant serum constituents.
For example, proteolysis within the tissue or deregulated
post-translational events participate in fragmentation of
proteins produced in the tumors that diffuse into the
circulation [22]. Disease biomarkers are often lowmolecular-weight proteins/peptides, exhibiting far
greater tumor and vascular permeability due to their
molecular size range, and are thus secreted into the
bloodstream as a result of the disease process. The Low
molecular weight fraction (LMWF) (≤ 25 kDa) plasma
or serum proteome has been the focus of recent attempts
to identify novel diagnostic and prognostic cancer
biomarkers [23, 24]. The LMWF holds much promise for
identification of diagnostics or prognostic markers,
further supported by recent associations of pathological
conditions with small protein and peptide profiles in
serum, notably for diabetes [25], cardiovascular or
infectious diseases [26]. The analytical capabilities of
traditional proteomic methods are limited given the large
dynamic range of concentrations in the serum. Therefore,
depletion of the highly abundant proteins is now
recognized as the first step, yet to be optimized, in the
analysis of the serum proteome. A key challenge in
identifying constituents in the LMWF in the serum is to
overcome the 10 orders of magnitude concentration
difference between the least abundant (interleukins,
cytokines < 5 pg/mL) and the most abundant (albumin:
up to 60 mg/mL).
Infrared and Raman spectroscopy have great potential for
serum based detection of disease biomarkers in serum
[27, 28]. However, the techniques suffer from similar
limitations to those encountered with chromatography
and/or mass spectroscopy based approaches. Highly
abundant proteins can strongly dominate the data
collected, making it difficult to detect small variations in
the features related to the presence of the informative
low molecular weight proteins/peptides [29]. This
present study details a proof of concept approach,
combining centrifugal filtration with Attenuated Total
Reflection infrared (ATR-IR) spectroscopy for the
detection of glycine (selected as a small model
biomolecule/biomarker) within the complex human
serum mixture. The filtration approach is an attractive
alternative to time consuming separation techniques such
as chromatography, offering a rapid and specific
fractionation of proteins according to molecular weight
without the need for chemical extraction that could affect
the spectral profiles recorded. The spectroscopic
approach is demonstrated as a highly sensitive, label free
method of detecting and quantifying the small molecule
within the LMWF.
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2. Experimental
2.1 Sample preparation
Sterile filtered human serum from normal mixed pool
(off the clot) was donated by the University Hospital
CHU Angers (France) as part of the Cancéropôle du
Grand-Ouest consortium. Commercially available
centrifugal filtering devices, Amicon Ultra-0.5ml
(Millipore - Merck, Germany), with cut-off points at 10
kDa, were employed in this study, as an illustrative
example. As a result, 2 fractions were obtained following
filtration; the first representing proteins with a molecular
weight higher than the cut off point of the filter used
(concentrate); the second corresponding to the fraction
passed by the membrane and collected in the vial
(filtrate). The serum was 1:10 diluted in distilled H2O
prior to processing, 0.5 mL of the solution being placed
in the centrifugal filter for spinning, in order to minimize
any potential effects of mechanical strain and clogging
on the filter membrane. The procedure for washing the
centrifugal devices prior to serum analysis was adapted
from [30], based on manufacturer’s guidelines, and
performed as follows: The Amicon Ultra-0.5ml filter was
spun thrice with a solution of NaOH (0.1M), followed by
3 rinses with Milli-Q water (Millipore Elix S). For both
washing and rinsing, 0.5 mL of the respective liquid was
added to the filters and the centrifugation was applied for
10 mins at 14 000g followed by a spinning with the
devices upside down at 1000g for 2 mins in order to
remove any residual solution contained in the filter.
Additionally, Albumin from human serum (SigmaAldrich, Ireland) and glycine (Cooper, France) were
analysed as reference chemical compounds for the
evaluation of the centrifugal filtration process. Notably,
glycine has been selected because it is the smallest
amino acid, having a molecular weight of 75 Da, which
results in free diffusion through the membrane of the
centrifugal filters and can serve as a model for LMWF
peptides. Firstly, the whole human serum sample has
been supplemented with known concentrations of
glycine; 0.0 mg/mL (control), 0.5 mg/mL, 1 mg/mL, 2.5
mg/mL, 5 mg/mL, 7.5 mg/mL, 10 mg/mL, 17.5 mg/mL,
25 mg/mL and 50mg/mL, in order to explore the
dynamic range and sensitivities of the ATR-IR
measurement of unprocessed samples. Therefore, the
concentrations has been selected to cover a wide range of
concentrations from extremely high, non-clinically
relevant, to relatively low in order to better understand
and explore the capabilities and behavior of the ATR-IR
instruments in humans serum monitoring. Secondly, a
stock solution corresponding to the LMWF, prepared
following centrifugal filtration with the 10kDa filters,
has been supplemented with known concentrations of
glycine of 0.01 mg/mL, 0.05 mg/mL, 0.1 mg/mL, 0.25
mg/mL, 0.5 mg/mL, 1 mg/mL, 2 mg/mL and 2.5 mg/mL.
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The serum stock solution without addition of glycine has
been used as a reference to build the regression models.

2.2 Dry mass measurements
In order to calculate total dry mass of the samples, it is
necessary to freeze-dry (lyophilize) the samples. Thus,
freeze drying was performed using a Labonco lyophilizer
(Freezone, USA), whereby the vials have been placed
overnight at -51°C and under vacuum (<0.05 mBar).
This procedure has been applied on sets of whole human
serum (n =3) and following ultrafiltration with a 10kDa
filter (n=3) to estimate to overall dry mass but also
determine the amount of biological material recovered in
the filtrated fractions, corresponding to the LMWF.

2.3 Data collection using the ATR-IR
ATR-IR spectra were recorded using a Bruker vector 22
equipped with a UATR module. Sample penetration is
both wavenumber and sample dependent, but is typically
on the order of 1µm. Spectral data were the result of 16
scans, with a spectral resolution of 4 cm-1 covering the
spectral window 4000 – 600 cm-1. A background
spectrum was also recorded (64 scans) and automatically
rationed with the sample spectrum by the software.
Whole human serum: The spectroscopic analysis of
samples was performed directly after deposition of a
drop on the crystal (0.5 µL, to ensure sample coverage is
less than the full area of the crystal, minimizing the
effects of inhomogeneities), while still in liquid form and
also in a dry state following 10 min air drying prior to
recording. 10 replicates have been performed for each
serum sample.
Filtered fraction of the human serum: The relatively
weak concentrations of the filtrates (LMWF) following
centrifugal filtrations using a 10kDa filter have been
found to greatly impact on the spectral data collected.
The freeze drying process was therefore used to reconcentrate the molecules present in the LMWF. Based
on a protocol detailed above, 400 µL of the filtrate were
processed and the resulting lyophilized material was resuspended in distilled water (20 µL). However, the
recording of IR spectra from the LMWF in the liquid
form has still been found not relevant due to the signal to
noise ratio exhibited and only air drying of the drops
deposited on the crystal has allowed to generate relevant
data. Similarly to whole human, 0.5 µL has been
deposited on the crystal and 10 replicates have been
performed for each sample.

Journal header will be provided by the publisher

2.4 Size exclusion chromatography (SEC)
SEC was performed on an Alliance e2695 (Waters)
equipped with both Wyatt miniDawn Treos and Optilab
T-rEx (Wyatt Technology Europe GmbH) detectors. 50
µL of each serum sample was injected onto A SHODEX
KW803 column (300 mm x 7.8 mm) and separated at a
flow rate of 0.7 mL/minute using PBS (pH 7.2) as
elution buffer. The PDA 2998 apparatus (Waters) was
employed for the UV detection at 280 nm, while the
MALLS detection was performed with a three-angle
(43.6°; 90.0°; 136.4°) miniDawn Treos detector (Wyatt
Technology Europe) operating with a 60-mW solid-state
laser at 658 nm. For consistency, a total elution time of
25 mins was used for all samples. The whole serum
being highly concentrated, a 1:50 dilution was prepared
prior to SEC analysis. In comparison, the LMW filtrates
were analyzed without any further dilution, since they
were obtained after centrifugal filtration performed on
diluted serum (1:10).

2.5 Data pre-processing and analysis
The different pre-processing and data analysis steps were
performed using Matlab (Mathworks, USA) with the
unsupervised attribute of Principal Component Analysis
(PCA) exploited as an approach to highlight and quantify
the spectral variability generated by the addition of
known concentrations of glycine to the human serum.
The analysis of the spectra collected has been restricted
to the finger print region where the water contribution is
less pronounced. While the spectra collected from liquid
samples have been min-max normalised on the water
band at 1636 cm-1, the spectra collected from the air
dried whole serum and the filtered samples (LMWF)
were processed using baseline correction (rubber-band)
followed by vector normalization. This enabled the
observation and evaluation of the systemic variations in
the data following the increased of glycine with the PCA
analysis. Vector normalization has been found to be
particularly suitable for this study in order to equalize the
contribution of the different serum physiological
constituents in the spectra collected between sets and
further enhance the systematic variations in the glycine
features. Ultimately the PCA analysis performed on the
whole finger print region reflects the evolution of band
ratios in the data, such that the features of the mixed pool
serum act as internal standards such that the added
glycine can be quantified. It should be noted that, for
each tested condition the lowest concentration of glycine
prepared (0.5 mg/mL or 0.01 mg/mL) has been excluded
from the regression model and kept as a blinded sample
to verify and validate the robustness of the method.
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3. Results and discussion

3.1 ATR-IR detection of a single model
biomolecule
Analysis of molecules using infrared spectroscopy can
be performed following a number of different set ups,
depending on the instrumentation available. Most
traditionally, the spectra are recorded using the
transmission mode, involving the IR beam passing
through the sample. However, the ATR (Attenuated
Total Reflectance) mode is particularly adapted for the
analysis of highly concentrated liquid samples [31].
Notably, the approach does not require expensive
spectroscopic substrates and the planar, easily washable
surface offered by the crystal is an advantage for
repeated measurements. Therefore, a drop can be directly
deposited onto the crystal, delivering high quality spectra
without saturation that can be encountered with
transmission mode measurements [32]. Liquid samples
can be analysed and characterised using ATR-IR spectra,
but the sensitivity of the information collected directly
depends on the concentration of the solution. Figure 1
presents IR spectra collected from aqueous solutions of
glycine (200 mg/mL) using the ATR mode of solution
(‘wet’ sample) (Figure 1A) and following air drying
(Figure 1B). The limited spectral region of 1800-650cm-1
was chosen to avoid the regions of strong water
absorption in the liquid samples, and to minimise any
effects of incomplete drying in dried samples, thus
enabling better comparison between liquid and dried
samples. While the spectrum obtained from the solution
exhibits the specific features of glycine, the contribution
of the spectrum of deionised water can still be observed
(dotted line). However, specific features of glycine such
as CH2 rocking (914 cm-1), C-N stretching (1039 cm-1),
N-H3 rocking (1117 cm-1), C-H2 wagging (1333 cm-1) or
O-C=O symmetric stretching (1412 cm-1) are easily
identifiable. The band at 1333 cm-1 is particularly
interesting due to its strong relative intensity but also its
positioning remote from the main water band (1636 cm1
), and is thus used for further analysis in Figure 2. The
spectrum collected from the solution of glycine
following air drying (Figure 1B) exhibits notable
modifications that could result from aggregation and/or
crystallization effects (e.g. bands between ~1100 – 1150
cm-1). The main spectral features are, however,
preserved.
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Figure 1: Typical ATR IR spectrum collected from solution
(‘wet’ samples) of glycine at 200 mg/mL deposited on the ATR
crystal (A) and after air-drying (B). No preprocessing has been
applied. Additionally the dotted line represents the contribution
of the water to the signal collected from the solution. The
spectra have been offset for clarity and the main features of
interest are highlighted in grey.

Figure 2 presents the concentration dependence of the
area under the curve observed in raw data (AUC –
between baseline and peak maximum) calculated for the
band 1360-1280 cm-1 from solution of glycine (figure 2 –
blue) and following air drying (figure 2 - red). Note, the
spectra have not been normalized. In the case of the
liquid samples, the thickness of the droplet exceeds the
penetration depth of the ATR evanescent wave, and the
systematic increase of the solution concentration results
in a linear correlation between the concentration of
glycine and the intensity of the signal (R2 = 0.9999), in
accordance with the Beer-Lambert law. In the dry
sample, all the dissolved glycine is deposited on the
crystal surface and therefore is sampled by the
evanescent wave, resulting in a substantially larger
absorbance for all concentrations and a steeper initial
increase in the concentration dependence. However, the
linearity of the measurement response is lost when the
thickness of the dried sample exceeds the depth of
penetration of the evanescent wave. Therefore, as seen in
figure 2 (red dots), above 25 mg/mL there is a saturation
of the IR absorbance. Indeed, this effect can only be
clearly seen in unprocessed data collected from dry
samples, as the commonly employed normalization steps
of the preprocessing protocol would compensate for the
loss of intensity in the spectra. However, the
observations highlight the fact that, following air drying,
the Beer-Lambert type dependence of the absorbance on
concentration and length of the optical path are both
partially lost and the critical parameter is the amount of
matter deposited. Thus, while a linear dependence of the
absorbance is observed over a wider range for the liquid
samples, for the dried samples, increased sensitivity is
achievable at the lower end of the concentration range.
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Figure 2: Evolution of Area Under the Curve (AUC) of the
band 1360-1280 cm-1 as a function of glycine concentrations.
The blue squares represent the measurement performed from
the sample in liquid form while the red dots correspond to the
samples deposited after air-drying. The dotted line represents a
linear fit to the liquid form data.

3.2 Analysis of human blood serum
Although recording reproducible IR spectra from human
serum could appear an easy task due to the particularly
high concentration of protein content, specificity towards
detection of minority species could be severely limited
because of the complexity of the signal collected.
Although human serum is naturally highly concentrated,
spectra collected for the liquid form are still dominated
by the water contribution (Figure 3A). In contrast, the
water free spectrum collected after air drying (Figure 3B)
displays numerous well defined peaks within the 4000650 cm-1 spectral widow, allowing clearly identification
of specific features of the human serum, for example
those highlighted in grey at 3280 cm-1 (H–O–H
stretching), 2957 cm-1 (Asymmetric CH3 stretching),
2920 cm-1 (Asymmetric CH2 stretching), 2872 cm-1
(Symmetric CH3 stretching), 1536 cm-1 (Amide II of
proteins), 1453 cm-1 (CH2 scissoring), 1394 cm-1 (C=O
stretch of COO–), 1242 cm-1 (Asymmetric PO2 stretch),
1171 cm-1 (Ester C–O asymmetric stretch) and 1080 cm-1
(C–O stretch) [33-35]. However, the dried serum
spectrum is very similar to the spectrum collected from
similarly dried human serum albumin (HSA), as a result
of its high concentration in human serum (Figure 3D).
This example perfectly illustrates the spectral dominance
that can be observed from the contributions of the
abundant proteins of the HMWF (Figure 3C). The
spectra of these proteins swamp the contribution of less
represented biomolecules, raising the question to
whether or not minor variations of minority components
can be detected and quantified.
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Figure 3: Typical ATR IR spectrum of a 5 mg/mL air dried
human serum albumin solution (A) compared to the HMWF
concentrated with a 10kDa filter (B); the human unfiltered
serum following air drying (C) and in its liquid form (D).
Spectra have been offset for clarity with the main features
highlighted in grey. No spectral preprocessing has been
applied.

3.3 Detection of Molecules in human serum
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Thus, a wide range of concentrations has been used for
the analyses which have been performed in both liquid
and dried forms, in order to evaluate the sensitivity and
determine the specificity offered by the experimental set
up used. Concentrations covering the range 0.5 mg/ml to
50 mg/mL have been found most suited to illustrate the
capabilities of the ATR-IR toward whole human serum
analysis. Although the concentrations used for
illustration are not necessarily physiologically relevant,
the limits of the tested range have been purposely
extended in order to offer better appreciation of the
spectral behavior for various amounts of glycine. The
mean IR spectra collected from the different samples
prepared (liquid) are presented in figure 4A, organized
from bottom to top according to the concentrations of
glycine added to the whole human serum, and off-set for
clarity. A stock solution of human mixed pool serum has
been used in this study in order to have a consistent basis
for the preparation of the samples and ensuring that the
chemical composition only varies based on the added
quantities of glycine.

In order to build a model to mimic variations that could
naturally occur in the LMWF, pure lyophilized glycine
has been added at known and variable concentrations to
human serum. Following the collection of ATR-IR
spectra, the capabilities of the technique have been
evaluated through the monitoring of systematic spectral
modifications in the data sets, despite the presence of
dominant HMW proteins.

Figure 4: A: Mean ATR-IR spectra collected from
unprocessed whole human serum (a) and supplemented with
0.5 mg/mL, 1 mg/mL, 2.5 mg/mL, 5 mg/mL, 7.5 mg/mL, 10
mg/mL, 17.5 mg/mL, 25 mg/mL and 50 mg/mL of glycine
(respectively b-j)- Spectra offset for clarity; B: Scatter plot
from the PCA performed on ATR-IR spectra collected from the
different solutions. Colour coding has been used to better
identify the different groups of spectra. The top arrow indicates

Copyright line will be provided by the publisher
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the distribution of the data across the scatter plot according to
concentrations of glycine added; C: Loadings 1 and 2
corresponding to the PCA analysis performed on serum
solutions (respectively blue and red); D: Linear regression fit of
ATR-IR absorption versus concentration of glycine in whole
human serum in solution. The plot represents the distance
between each groups and the un-supplemented serum (0
mg/mL) calculated using the PC_1 score from the PCA.

The data collected from the samples have been analyzed
by Principal Component Analysis (PCA), delivering, in
an unsupervised fashion, the variance between the data
sets, either graphically with the scatter plot or through
the loadings expressing the discriminating spectral
features [36]. The results corresponding to the PCA
performed on spectra collected from the liquid samples
supplemented with glycine compared to the unsupplemented serum stock solution are presented in
figure 4B. The distribution along the PC 1 axis is directly
related to the variation of concentration of glycine added
to the human serum, an observation confirmed by the
loading of PC1, accounting for 98.12% of the variance
and displayed in figure 4C.
While a clear discrimination between the different
clusters can be seen at the highest concentrations (figure
4B top arrow), the degree of separation is strongly
reduced when the concentrations of glycine added are
below 10 mg/mL, especially for the 2.5 mg/mL (yellow
dots), 1 mg/mL (blue dots) and 0.5 mg/mL (green dots).
PC 2 only accounts for 0.58% of variance which
indicates quite minor variations in the spectra collected.
The spectral profile of PC2 (Figure 4B) does not clearly
correlate with the glycine spectrum. The positions of the
different clusters formed by the spectra along the PC 2
axis are, however, not correlated with the concentration
of glycine and the inter and intra cluster variability could
thus be attributed to instrumental or experimental
variability.
While the loading of PC 1 exhibits a spectral profile
identical to the pure solution of glycine (figure 1A), the
loading of PC 2 (figure 4Cb) is particularly noisy and
does not exhibit any clear features which can be
unambiguously related to spectral features of glycine
(data not shown). This is further supported by the 0.58%
of variance expressed by PC 2, clearly highlighting the
absence of relevant discriminative information along this
PC. It should be noted that, in order to remove the tail
effect visible in figure 4A due to the presence of water in
the liquid samples, the PCA analysis has been performed
on the range 1800-1000 cm-1.
PCA remains a powerful tool, widely employed for data
mining and in particular for studies aiming to
discriminate data groups for diagnostic purposes [36].
The chemical information obtained from the loadings
allows correlation of the distribution of the data points
across the scatter plot with specific variations in the
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spectra, and, in this instance, to confirm the contribution
of the glycine signature to the observed variance.
Moreover, the location of each spectrum in the
scatterplot is defined by scores along both PC 1 and PC 2
(figure 4B) which can be assimilated to coordinates
positioning the groups with respect to each other.
Therefore, the most different spectra, according to a
specific PC, will be separated by a greater distance than
those exhibiting stronger similarities. Ultimately, when
the limit of specificity of the information contained in
the spectra has been reached, no more discrimination
would be discernible on the scatter plot, meaning that,
score wise, the spectra would be characterized by similar
values along the relevant PC.
To represent this, firstly, the mean score values for each
tested concentration of glycine are evaluated for PC 1
using Mi = ∑scores/ni (with ni = number of spectra for a
given concentration). Secondly, the distance between
each group and the un-supplemented serum (0 mg/mL)
has been calculated (∆PC = Mi – M0 mg/mL). Finally, the
degree of separation has been expressed using Eq.1:

xi = (∆PC_1i2)1/2

(1)

(i: different concentrations tested )

Considering the case of liquid human serum, PC 2,
accounting for only 0.58% of the variance, can be
disregarded, as there is no clear correlation with the
systematic change in concentration. Finally, the values
calculated can be plotted against the different
concentrations of glycine added in the whole serum, as
presented in figure 4D. The results for the analysis of
liquid samples display acceptable linearity (R2 = 0.9993).
Note that the regression model has been built without
taking onto account the lowest concentration, 0.5
mg/mL, which has been then used as a blinded sample to
evaluate the sensitivity of the methods. Accordingly, the
10 replicates from the 0.5 mg/mL sample have been
inputted into the regression model giving an average
predicted value of 0.45 mg/mL +/- 0.16 mg/mL.
In order to better evaluate the impact of working from
liquid serum samples, the drops deposited on the ATR
crystal have been air dried before recording in order to
collect water free spectra. The resulting mean spectra are
displayed in figure 5A, and the corresponding results
from the PCA are presented in figure 5B, 5C and 5D.
The absence of water bands greatly improves the
visibility of the different features resulting from both the
human serum constituents and the added glycine. The
distribution of the different groups of spectra on the
scatter plot follows a different pattern, both PC 1 and PC
2 being influenced by the presence of the glycine. As a
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consequence, the loadings 1 and 2 exhibit similar
spectral features of this model amino acid and they
respectively account for 98.2% and 1.4% of the
explained variance. However, the spectra collected from
the samples supplemented with 50 mg/mL glycine have
been considered as outliers and excluded from the data
set to build the regression model. It appears that such
high concentration generated a quite different spectral
profile, potentially due to aggregation, leading to
difficulties in interpreting the peak position and intensity
compared to lower concentrations (figure 5A).
Therefore, although the PC 2 expresses 1.4% of the
explained variance it has been considered that most were
related to the position of the 50 mg/mL spectra. Finally,
only the PC 1 was used for the calculation of the degree
of separation between the different clusters formed on
the scatter plot, as described in equation (1).
The curve obtained from the PC 1 score according to
Equation 1 exhibits quite a different profile compared to
the liquid samples, as seen in figure 5D, with a deviation
from linearity apparent above ~ 10mg/mL, similar to the
case for dried glycine in Figure 1. The relationship
between the glycine concentration in the serum and the
variations observed in the spectra can be expressed by
means of a polynomial fitting, giving a R2 value of
0.9978. Polynomial expansions are common in the
mathematical description of many physical phenomena,
including perturbation theory of, for example an
anharmonic oscillator, or non-linear optics. In the case of
concentration dependent effects, higher order terms are
commonly employed to account for intermolecular
interactions, e.g. aggregation [37]. Similar to the liquid
samples, the spectra collected from the 0.5 mg/mL
samples have been inputted into the regression model,
delivering a predicted value of 0.383 +/- 0.007 mg/mL.
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Figure 5: A: Mean ATR IR spectra collected from unprocessed
whole human serum (a) and supplemented with 0.5 mg/mL, 1
mg/mL, 2.5 mg/mL, 5 mg/mL, 7.5 mg/mL, 10 mg/mL, 17.5
mg/mL, 25 mg/mL and 50 mg/mL of glycine (respectively b-j)
- offset for clarity; B: Scatter plot from the PCA performed on
ATR-IR spectra collected from the different solutions. Colour
coding has been used to better identify the different groups of
spectra. The top arrow indicates the distribution of the data
across the scatter plot according to concentrations of glycine
added; C: Loadings 1 and 2 corresponding to the PCA analysis
performed on serum-based solutions (respectively blue and
red); D: Polynomial regression fit of ATR-IR absorption versus
concentration of glycine in whole human serum in solution.
The plot represents the distance between each groups and the
un-supplemented serum (0 mg/mL) calculated using the PC_1
score from the PCA.

The ATR-IR measurement setup used in this study is
perfectly suited for the analysis of complex mixtures.
The direct deposition of solutions onto the crystal would
offer the two options to collect the data from the liquid
samples or following air drying. Ultimately, high quality
spectra capturing the overall chemical composition can
be collected, as highlighted with the unprocessed data
displayed in figure 1 and figure 3. Both approaches
deliver predicted values in the range of the blinded
samples tested, although they underestimate the real
concentration. Although removing a dominant molecule
such as H2O from the signal collected could be expected
to enhance the relative contribution of other weaker
bands, resulting in a better separation of the different
data groups, only the standard deviation has been
improved but the accuracy remains unacceptable.
Although those results are encouraging, in the context of
human serum analysis, the difficulty comes from
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unbalanced concentrations existing between the different
constituents. For example, Albumin itself represents
about 50% of the overall composition which, combined
with other abundant proteins such as immunoglobulin,
fibrinogen or transferrin, brings this number up to 90%.
As a result, the LMWF of the serum represents only 1%
of the total composition [21]. Therefore, similar to other
approaches to identifying serum biomarkers, such as
chromatography and mass spectroscopy [22], the
potential of vibrational spectroscopy techniques could
also be greatly improved when coupled with optimised
sample preparation methods aiming to isolate the LMWF
for more specific spectral characterisation.

3.4 Centrifugal filtration and HMW protein
depletion
Mass spectroscopy is the most commonly reported
technique for the recent investigations screening the
LMWF for disease-related information, probing and
profiling proteomic information of hundreds of candidate
disease biomarkers without the need for a priori
knowledge of their existence or relevance to disease
states [39-41]. Facing the complexity of human serum,
most approaches aiming for the identification and
validation of LMWF diagnostic biomarkers have
introduced HMWF depletion in their protocols [42].
Although ATR-IR spectroscopy is an attractive, rapid
and cost effective alternative for the screening of patient
samples in order to deliver a specific diagnostic,
similarly to mass spectroscopy, the depletion of abundant
proteins (HMWF) is a non-optional step in the
investigation of the relevant fraction of the serum, in
order to highlight and potentially target small circulating
biomolecules. When applying vibrational spectroscopy
techniques for rapid screening of human body fluids,
numerous constraints towards the integrity of the
samples need to be considered in order to provide an
adapted and optimised methodology. While a wide range
of chemical extraction/precipitation protocols of the
HMWF can be found in the literature [43, 44], the impact
of the solvents involved in the different steps is unclear,
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considering that most of them would exhibit strong IR
features, contributing to the spectra collected, adding
complexity to the identification of specific spectral
variations in serum biomolecules. Commercially
available centrifugal filtration devices such as the
Amicon ultra-0.5 (Merk Millipore) provide, as stated by
the manufacturer, “a fast ultrafiltration, with the
capability for high concentration factors and easy
concentrate recovery from the dilute and complex
matrices”. This aspect has already been explored in
previous studies which demonstrated that the
concentrating factor of 10, when centrifuging human
serum at 14000g for 30 mins, offers possibilities for
analysing samples in liquid form with both IR and
Raman spectroscopy [33]. The main advantage of this
approach resides in the centrifugal separation of the
molecules based on their sizes without the need for
additional solvents, resulting in the preservation of the
biomolecules from the serum as close as possible to their
native forms. Another attractive aspect of the centrifugal
centrifugation for biomedical applications is the
possibility to collect both the concentrated HMW and the
filtered LMW fractions. For instance, using a 10kDa cutoff point, the depletion of abundant proteins with high
molecular weight can be achieved, as only small
biomolecules are able to freely pass through the
membrane, providing a perfectly suited in vitro tool for
quick separation of molecular species for subsequent
spectroscopic characterisation [45].
Evaluation of the efficiency of the HMW protein
depletion has been performed based on size exclusion
chromatography (Figure 6). The whole unprocessed
human serum, presented in Figure 6A, has been used as
reference in order to visualise the different features
present and defined windows on the chromatogram
corresponding to relevant elution times. The regions
corresponding to the HMWF and LMWF have been
highlighted and are respectively found between elution
times of 9-15 mins and 19-22 mins. The dominant peak,
positioned at 14 mins, corresponds to the contribution of
albumin, the most abundant protein in human serum
(Figure 6B). Comparison of the data collected from
unprocessed (Figure 6A) and 10kDa filtered human
serum samples (Figure 6C) clearly highlights a strong
decrease in the intensities of the bands located in the
HMWF window of the chromatogram. In order to enable
a better estimation of the degree of depletion achieved,
the Area Under the Curve (AUC) for the albumin peak
was calculated. Considering the dilution factors used for
the sample preparation, an average of 0.16% remaining
albumin can be found in the samples following
centrifugal filtration (Table 1). Although, only done in
triplicates, the reproducibility of the HMW proteins
depletion has been found quite acceptable with
remaining percentages of albumin comprised between
0% and 0.37%. According to the chromatogram, most of
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the HMWF proteins are characterised by higher
molecular masses, with elution times between 9-14 mins
(Figure 6A). Therefore, an efficient depletion of the
albumin would also impact on the other abundant
proteins. Finally, the LMWF has been found to be totally
preserved during the centrifugal filtration process. A
similar AUC analysis for the peak located around 20
mins, estimated values of 0.188 +/- 0.004 and 0.190+/0.012 for the whole unprocessed and the 10kDa filtered
human serum respectively (Figure 6A and 6C).

Dilution factor

50

10

% HSA (average)

100% (reference)

0.16%

Figure 6: Size Exclusion Chromatography performed on A:
Whole serum (1:50 dilution); B: Human serum albumin (1
mg/mL); and C: Filtrate obtained from human serum after
centrifugal filtration using a 10kDa device (serum diluted 1:10
prior to centrifugation) and Chromatograms off set for clarity.
The regions corresponding to the High Molecular Weight
Fraction (HMWF) and the Low Molecular Weight Fraction
(LMWF) have been highlighted.

Table 1: Area Under the Curve (AUC) calculated for the
albumin peak observed in the chromatograms displayed in
figure 6. The percentage of Albumin (Alb) takes into account
the dilution factors used for the sample preparation.
Whole serum
Filtrate (10kDa)
AUC (min-max)

0.4725 - 0.5048

0 – 0.0115

AUC (average /
STD)

0.489 +/- 0.023

0.004 +/- 0.0053

Vol injected (µl)

50

50
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filtered part of the serum. The glycine, selected as a
model, being the smallest amino acid, will freely pass
through the centrifugal device membrane and be
collected with the LMWF. Samples of whole serum and
filtrates obtained from centrifugal filtration with 10kDa
filters have been prepared by freeze drying and weighing
of lyophilisates was performed to quantify the amounts.

3.5 Centrifugal filtration for human serum
LMWF spectroscopic analysis

Figure 7: A: Mean ATR IR spectra collected from the
ultrafiltetered human serum (a) and supplemented with 0.01
mg/mL, 0.05 mg/mL, 0.1 mg/mL, 0.25 mg/mL, 0.5 mg/mL, 1
mg/mL, 2 mg/mL and 2.5 mg/mL of glycine (respectively b-i)offset for clarity; B: Scatter plot from the PCA performed on
ATR-IR spectra collected from the different solutions. Colour
coding has been used to better identify the different groups of
spectra. The top arrow indicates the distribution of the data
across the scatter plot according to concentrations of glycine
added; C: Loadings 1 and 2 corresponding to the PCA analysis
performed on serum solutions (respectively blue and red); D:
Polynomial regression fit of ATR-IR absorption versus
concentration of glycine in whole human serum in solution.
The plot represents the distance between each groups and unsupplemented serum (0 mg/mL) calculated using the PC1 score
from the PCA.

Following centrifugal filtration using 10kDa filters, the
depletion of abundant proteins can be efficiently
achieved as highlighted using exclusion chromatography.
The removal of the HMWF will naturally have huge
consequences on the IR spectra collected from the
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In the present case, the serum stock solution used in this
study has an initial concentration of 98.5 +/- 0.2 mg/mL,
taking into account all molecular species naturally
present in the serum, while, after processing with
centrifugal filtration, the LMWF was found to be 13.3
+/- 0.5 mg/mL. Therefore, the range of concentrations of
glycine analysed for filtered human serum has been
considerably reduced, extending from 0.01 mg/mL to 2.5
mg/mL. The mean spectra collected from the different
LMWF dry samples are presented in figure 7. Based on a
similar approach to the one used previously on whole
serum, the position for each group of data has been
estimated according to the scores corresponding to PC 1
(see equation 1) and a correlation curve has been drawn.
Once again, the curve follows a polynomial pattern and a
trend line can be fitted with R2 = 0.9981. Following
depletion of the abundant proteins, the sensitivity for the
detection of glycine has been considerably improved and
the regression model built allows to deliver a predicted
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value of 0.011 mg/mL +/- 0.006 mg/mL, for the
0.01mg/mL sample. Although the standard deviation
remains quite high compared to the average predicted
value, the depletion of HMW proteins greatly enhanced
the sensitivity of the method. The main limitations
encountered remain purely technical, as both the LMWF
fraction and the added glycine are particularly low in
concentrations which make the data collected strongly
influenced by the reproducibility of the drops deposited.
A much lower standard deviation could easily be
achieved using an automated system for deposition
rather than micropipettes which could lead to
uncertainties.

3.6 Discussion
The focus in the field of clinical serology has recently
been shifted to an unexplored reservoir of potentially
relevant biomolecules gathered in the LMWF of the
proteome, incorporating their metabolic products
(peptidome). While the LMWF serum peptidome has
been dismissed as too small to be biologically relevant, it
has been also been reported that this fraction may contain
a rich, untapped source of disease-specific diagnostic
information [45, 46]. The low molecular mass range
(<10 kDa) remains largely uncharacterized but promises
to contain a precious source of previously undiscovered
biomarkers, mostly because it has now been recognized
to contain shed proteins and protein fragments (clipped
or cleaved) originating from physiologic and pathologic
events taking place in all perfused tissues [44, 46, 47].
While the size of HMW proteins prevents them from
entering the circulation, fragments from those could be
found in the serum proteome, mixed with the normal
constituents, the remaining challenge being to detect
them among the broad molecular population.
The metabolites are physiological constituents of the
human serum LMWF that can potentially reflect a
patient’s health status. Variations in their concentrations
can be a good indicator to detect undergoing pathological
processes, and therefore as physiological markers for
rapid diagnostics. Glucose remains the most common
example, but also one of most targeted molecules for the
development of ex vivo quantitative models, notably IR
spectroscopy [48, 49]. While the normal average
concentration for glucose is roughly about 0.8 mg/mL
[50], making its detection achievable in whole serum,
monitoring and estimation of its blood levels based on
spectral features will be significantly limited in the
presence of highly abundant proteins (HMWF). With a
molecular mass of 180 Da, glucose can freely pass
through the 10kDa centrifugal devices used is this work
and be collected entirely in the filtered fraction. That
means blood glucose levels could be determined more
accurately but also that the spectroscopic analysis could
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be used for patients with extremely low glucose levels
located in the range of a few µg/mL, which is not
achievable before HMWF depletion. Moreover, glucose
remains one of the most abundant metabolites found in
the human serum, which probably explains its recurrent
apparition in the literature. The methodology proposed
here opens numerous perspectives toward the broadening
of applications as a direct consequence of the isolation of
the LMWF to potentially reveal the contribution of
numerous other metabolites which will fall within the
lowered limit of detection range estimated [51]. For
instance, most amino acids can be found naturally in the
human serum, levels ranging from 0.262 mg/mL
(proline), to 0.0132 mg/mL (alanine) to 0.024 mg/mL
(glycine), 0.023 mg/mL (phenylalanine). Moreover, a
large number of other metabolites with clinical potential
for health monitoring can be found in human serum [50,
51], including, as examples, lactate (acid base
homeostasis), creatinine (renal health) or carnitine (heart
dysfunction), with respective normal concentrations
documented at 0.29 mg/mL, 0.009 mg/mL and 0.005
mg/mL, respectively [51]. Many serum analytical
techniques, for example, peptidomics, metabolomics etc.
also require depletion of the HMWF. Centrifugation can
processes many vials at the same time, and thus is much
faster than for example chromatographic separation
techniques. The study demonstrates the potential
advantages of spectroscopic methods over the
subsequent analysis techniques. Simplifying the serum
composition by depletion could lead to the development
of more suitable methods for in vitro diagnostics which,
coupled to the considerable improvements made in
recent years in the field of data preprocessing and
analysis, will allow accurate and reproducible models for
quantitative screening of key molecules present in the
LMWF to be built.

4. Conclusion

The rapid increase of scientific works referenced in the
literature demonstrates the growing interest in translating
and adapting the capabilities of vibrational spectroscopic
techniques to the development of serological diagnostic
methods. However, little or no consideration has been
given to the protocols employed for sample preparation,
leading to a poor relevancy of the outcomes due to the
high degree of complexity of the serum. Although
vibrational spectroscopy delivers the chemical
fingerprint of the analyzed samples, with, in principle,
contributions from all molecular species present, the
limit of detection found experimentally would suggest
that performing analysis on whole human serum will
imply negligible contribution from numerous
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constituents present at low concentrations. Human serum
screening, and by extension all body fluids, is still an
emerging field of application and in order to strengthen
the position of Infrared and Raman spectroscopy as
clinical tools, numerous questions need to be considered
and addressed by the community, firstly, to be in
accordance with other approaches currently used such as
Mass spectroscopy and secondly, be able to deliver
clinically relevant information for diagnosis. Adapting
and optimizing sample preparation methods have a
considerable impact on the sensitivity of the
spectroscopic analysis of the LMWF of the human serum.
The model built on glycine monitored by ATR-IR clearly
demonstrates that removal of water, by drying, and the
HMWF, by centrifugal filtration, leads to an
improvement of the sensitivity of the technique which
allowed to identify blinded concentrations of glycine up
to 50 times lower compared to whole human serum.
Furthermore, as the sample processing is also applicable
to a wider range of body fluids, the methodology
presented in the present work will certainly be beneficial
for the field and lead to drastic improvements in the
strategies oriented toward their implementation as the
next generation of diagnostics techniques clinical tools.
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Graphical Abstract for Table of Contents

Text:
The Low Molecular Weight Fraction (LMWF) of serum holds
great potential for diagnostics and health monitoring. The low
concentrations of peptides and metabolites compared to highly
abundant proteins remain a challenging obstacle to overcome.
In order to collect specific chemical fingerprint from small
serum biomolecules using vibrational spectroscopy techniques,
High Molecular Weight (HMW) proteins depletion is required.
Physical separation by mean of ultrafiltration offers a new
dimension in serological diagnostic and further support the
potential of Infrared and Raman spectroscopy as clinical tools.
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